With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer. In a recent study, scientists at the University of Chicago found that ...

Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.

Our diets can affect our health, but despite extensive research, we still don’t have a great understanding ... | Cell And Molecular Biology ...

Systemic lupus erythematosus is a clinically and immunologically heterogenous, systemic autoimmune disease characterized by ...

Natural antihistamines such as black pepper extract, vitamin C, butterbur, and quercetin may help provide relief for ...

Peptides called alpha-defensins shape which gut bacteria thrive and which are weeded out, revealing that our bodies aren't ...

Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

Dr. Raffi Tachdjian, a leading allergist and immunologist, was recently named the first-ever recipient of the Aram V.

In a new study, researchers from the University of Chicago discovered that zeaxanthin, a plant-derived carotenoid best known for protecting vision, may also act as an immune-boosting compound by ...

After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and ...